Analgesics in Estonia

Date: November 23, 2016
Pages: 22
Price:
US$ 990.00 US$ 792.00
Offer valid until July 31, 2017!
Publisher: Euromonitor International Ltd
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: AB3D2DF203BEN
Leaflet:

Download PDF Leaflet

Based on active substances, analgesics could be divided to three main categories - ibuprofen, acetaminophen (paracetamol) and acetylsalicylic acid (aspirin). Ibuprofen has taken the lead and paracetamol has increased its share at the expense of acetylsalicylic acid. Paracetamol was usually the first choice to treat fever and slight pain in adults and children. Sales of paracetamol increased by 8% in 2016 to EUR2 million, which was half of ibuprofen’s sales. While single purpose paracetamol was s...

Euromonitor International's Analgesics in Estonia report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2011-2015, allowing you to identify the sectors driving growth. Forecasts to 2020 illustrate how the market is set to change.

Product coverage: Systemic Analgesics, Topical Analgesics/Anaesthetic.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report
  • Get a detailed picture of the Analgesics market;
  • Pinpoint growth sectors and identify factors driving change;
  • Understand the competitive environment, the market’s major players and leading brands;
  • Use five-year forecasts to assess how the market is predicted to develop.
Euromonitor International has over 40 years' experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town, Santiago, Sydney, Tokyo and Bangalore and a network of over 800 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.
Headlines
Trends
Competitive Landscape
Prospects
Category Data
  Table 1 Sales of Analgesics by Category: Value 2011-2016
  Table 2 Sales of Analgesics by Category: % Value Growth 2011-2016
  Table 3 Sales of Topical Analgesics/Anaesthetic by Format: % Value 2011-2016
  Table 4 NBO Company Shares of Analgesics: % Value 2012-2016
  Table 5 LBN Brand Shares of Analgesics: % Value 2013-2016
  Table 6 Forecast Sales of Analgesics by Category: Value 2016-2021
  Table 7 Forecast Sales of Analgesics by Category: % Value Growth 2016-2021
Tallinna Farmaatsiatehase As in Consumer Health (estonia)
Strategic Direction
Key Facts
  Summary 1 Tallinna Farmaatsiatehase AS: Key Facts
  Summary 2 Tallinna Farmaatsiatehase AS: Operational Indicators
Competitive Positioning
  Summary 3 Tallinna Farmaatsiatehase AS: Competitive Position 2016
Executive Summary
Health Products' Retail Value Growth
Pharmacy Reform and Healthy Lifestyles
Intense Competition
Internet Retailing Is Gaining Importance
Modest To Moderate Growth Predicted in the Forecast Period
Key Trends and Developments
Pharmacy Reform and Vertical Integration
Strategic Importance of A Healthy Lifestyle
Market Indicators
  Table 8 Consumer Expenditure on Health Goods and Medical Services: Value 2011-2016
  Table 9 Life Expectancy at Birth 2011-2016
Market Data
  Table 10 Sales of Consumer Health by Category: Value 2011-2016
  Table 11 Sales of Consumer Health by Category: % Value Growth 2011-2016
  Table 12 NBO Company Shares of Consumer Health: % Value 2012-2016
  Table 13 LBN Brand Shares of Consumer Health: % Value 2013-2016
  Table 14 Distribution of Consumer Health by Format: % Value 2011-2016
  Table 15 Distribution of Consumer Health by Format and Category: % Value 2016
  Table 16 Forecast Sales of Consumer Health by Category: Value 2016-2021
  Table 17 Forecast Sales of Consumer Health by Category: % Value Growth 2016-2021
Appendix
OTC Registration and Classification
Vitamins and Dietary Supplements' Registration and Classification
Self-medication/self-care and Preventive Medicine
Switches
  Summary 4 OTC: Switches 2014-2016
Definitions
Sources
  Summary 5 Research Sources












Skip to top


Calming and Sleeping in Estonia US$ 792.00 Jul, 2013 · 22 pages
Digestive Remedies in Estonia US$ 792.00 Nov, 2016 · 19 pages
Ear Care in Estonia US$ 792.00 Jul, 2013 · 17 pages
Emergency Contraception in Estonia US$ 792.00 Jul, 2013 · 16 pages

Ask Your Question

Analgesics in Estonia
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: